Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-06-11 Sale | 2026-06-15 8:58 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X Chairman, CEO and Interim CFO 10% Owner | 18,124 | $3.8817 | $70,352 | 332,715 (Indirect Direct) | View |
| 2026-06-08 Sale | 2026-06-10 8:26 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X Chairman, CEO and Interim CFO 10% Owner | 22,385 | $4.1677 | $93,294 | 350,839 (Indirect Direct) | View |
| 2026-06-03 Sale | 2026-06-05 5:26 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 8,285 | $4.3704 | $36,209 | 373,224 (Indirect Direct) | View |
| 2026-05-29 Sale | 2026-06-02 8:34 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 652 | $4.7156 | $3,075 | 381,509 (Indirect Direct) | View |
| 2026-05-11 Sale | 2026-05-29 4:30 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 12,763 | $5.4416 | $69,451 | 382,161 (Indirect Direct) | View |
| 2026-05-22 Sale | 2026-05-26 9:06 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 1,165 | $5.69 | $6,629 | 214,924 (Indirect Direct) | View |
| 2025-12-29 Sale | 2025-12-31 4:05 pm | Cadrenal Therapeutics Inc. | CVKD | Szot Matthew K Chief Financial Officer | 9,933 | $6.97 | $69,233 | 0 (Direct) | View |
| 2025-10-24 Sale | 2025-10-28 5:00 pm | Cadrenal Therapeutics Inc. | CVKD | Szot Matthew K Chief Financial Officer | 3,600 | $13.99 | $50,364 | 9,933 (Direct) | View |
| 2025-10-24 Sale | 2025-10-28 5:00 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 2,444 | $14.01 | $34,237 | 396,089 (Indirect Direct) | View |
| 2025-10-09 Sale | 2025-10-14 4:05 pm | Cadrenal Therapeutics Inc. | CVKD | Szot Matthew K Chief Financial Officer | 3,493 | $14.03 | $49,011 | 13,533 (Direct) | View |
| 2025-10-09 Sale | 2025-10-14 4:05 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 3,600 | $14.09 | $50,706 | 398,533 (Indirect Direct) | View |
| 2025-10-06 Sale | 2025-10-07 8:22 pm | Cadrenal Therapeutics Inc. | CVKD | Szot Matthew K Chief Financial Officer | 107 | $13.99 | $1,497 | 17,026 (Direct) | View |
| 2025-10-02 Sale | 2025-10-03 8:24 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 500 | $14.13 | $7,065 | 402,133 (Indirect Direct) | View |
| 2025-09-29 Sale | 2025-10-01 5:47 pm | Cadrenal Therapeutics Inc. | CVKD | Szot Matthew K Chief Financial Officer | 1,800 | $13.99 | $25,183 | 17,133 (Direct) | View |
| 2025-09-29 Sale | 2025-10-01 5:46 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 1,300 | $14.01 | $18,213 | 402,633 (Indirect Direct) | View |
| 2025-09-24 Sale | 2025-09-26 8:36 pm | Cadrenal Therapeutics Inc. | CVKD | Szot Matthew K Chief Financial Officer | 12,400 | $14.05 | $174,175 | 18,933 (Direct) | View |
| 2025-09-24 Sale | 2025-09-26 8:35 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 9,371 | $14.06 | $131,779 | 403,933 (Indirect Direct) | View |
| 2025-08-27 Sale | 2025-08-29 8:35 pm | Cadrenal Therapeutics Inc. | CVKD | Szot Matthew K Chief Financial Officer | 2,000 | $14 | $27,992 | 31,333 (Direct) | View |
| 2025-08-27 Sale | 2025-08-29 8:34 pm | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 5,029 | $13.99 | $70,356 | 413,304 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-02 Option Award | 2025-12-03 8:08 pm | 2027-01-01 2035-12-01 | Cadrenal Therapeutics Inc. | CVKD | Golden Lee Scott Director | 5,000 | $0 | 5,000 (Direct) | View |
Ownership | 2025-12-03 8:07 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Golden Lee Scott Director | 0 | $0 | 1,667 (Direct) | View |
| 2025-01-23 Option Award(A) | 2025-03-24 8:38 pm | 2026-02-01 2035-01-22 | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 65,000 | $0 | 65,000 (Direct) | View |
| 2025-02-05 Option Award | 2025-02-06 4:51 pm | 2026-03-01 2035-02-04 | Cadrenal Therapeutics Inc. | CVKD | Ferguson James J. III Chief Medical Officer | 60,000 | $0 | 60,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-24 6:13 pm | 2025-02-01 2035-01-22 | Cadrenal Therapeutics Inc. | CVKD | MURPHY JOHN RAYMOND Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-24 6:13 pm | 2025-02-01 2035-01-22 | Cadrenal Therapeutics Inc. | CVKD | WILSON GLYNN Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-24 6:12 pm | 2025-02-01 2035-01-22 | Cadrenal Therapeutics Inc. | CVKD | Zelenkofske Steven Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-24 6:11 pm | 2026-02-01 2035-01-22 | Cadrenal Therapeutics Inc. | CVKD | Cole Jeffrey Scott Chief Operating Officer | 25,000 | $0 | 25,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-24 6:10 pm | 2026-02-01 2035-01-22 | Cadrenal Therapeutics Inc. | CVKD | Szot Matthew K Chief Financial Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-24 6:10 pm | 2026-02-01 2030-01-22 | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 65,000 | $0 | 65,000 (Direct) | View |
| 2025-01-23 Option Award | 2025-01-24 6:09 pm | 2025-02-01 2035-01-22 | Cadrenal Therapeutics Inc. | CVKD | Lisicki Robert Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-04-10 Gift | 2024-04-10 5:30 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 50,000 | $0 | 6,275,000 (Direct) | View |
| 2024-04-02 Option Award | 2024-04-03 5:21 pm | 2025-04-01 2034-04-01 | Cadrenal Therapeutics Inc. | CVKD | Cole Jeffrey Scott Chief Operating Officer | 150,000 | $0 | 150,000 (Direct) | View |
Ownership | 2024-04-03 5:19 pm | 2022-08-01 2032-07-10 | Cadrenal Therapeutics Inc. | CVKD | Cole Jeffrey Scott Chief Operating Officer | 0 | $0 | 200,000 (Direct) | View |
| 2023-10-23 Gift | 2024-02-12 9:41 pm | N/A N/A | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X CEO and Chairman 10% Owner | 85,000 | $0 | 6,325,000 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-19 7:41 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | Zelenkofske Steven Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-19 7:41 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | MURPHY JOHN RAYMOND Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-19 7:41 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | Lisicki Robert Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-19 7:40 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | Pham Quang X Chief Executive Officer 10% Owner | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-19 7:39 pm | N/A 2034-01-17 | Cadrenal Therapeutics Inc. | CVKD | Szot Matthew K Chief Financial Officer | 250,000 | $0 | 250,000 (Direct) | View |